Duloxetine Approved In EU For Stress Urinary Incontinence
Lilly and marketing partner Boehringer Ingelheim plan to launch duloxetine under the trade name Yentreve by year-end in the European Union. The NDA for Yentreve is pending at FDA.
Lilly and marketing partner Boehringer Ingelheim plan to launch duloxetine under the trade name Yentreve by year-end in the European Union. The NDA for Yentreve is pending at FDA.